(Q38196383)

30 August 2017

1 reference

title

A benefit-risk assessment of the use of proton pump inhibitors in the elderly (English)

1 reference

30 August 2017

3

Ernst J Kuipers

1 reference

30 August 2017

2

Miriam C J M Sturkenboom

1 reference

30 August 2017

Gwen M C Masclee

1

1 reference

30 August 2017

publication date

1 April 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

31

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

263-282

1 reference

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Persistence and adherence to proton pump inhibitors in daily clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Overuse of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Guidelines for prevention of NSAID-related ulcer complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Steroids and risk of upper gastrointestinal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Why we need observational studies to evaluate the effectiveness of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Overprescribing proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Overuse of acid suppression therapy in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Appropriateness of gastric antisecretory therapy in hospital practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Appropriateness of treatment recommendations for PPI in hospital discharge letters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Lack of symptom benefit following presumptive Helicobacter pylori eradication therapy in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Step-down management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Pharmacogenomics of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

CYP2C19 polymorphism and proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Drug interactions between proton pump inhibitors and antiretroviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Malabsorption of Thyroid Hormones After Jejunoileal Bypass for Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Conditions and drugs interfering with thyroxine absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of calcium carbonate on the absorption of levothyroxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Mortality following hip fracture: trends and geographical variations over the last 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Continuous decline in incidence of hip fracture: nationwide statistics from Finland between 1970 and 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Epidemiology of hip fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Chronic proton pump inihibitor therapy and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Acid-suppressive medications and risk of bone loss and fracture in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Increase in vertebral fracture risk in postmenopausal women using omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Bone density in proton pump inhibitors users: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Long-term proton pump inhibitor therapy and risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Use of proton pump inhibitors and risk of osteoporosis-related fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitors and bone fractures?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Meta-analysis: risk of fractures with acid-suppressing medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton-pump inhibitor use and the risk for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Clinical practice. Vitamin B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Do acid-lowering agents affect vitamin B12 status in older adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Helicobacter pylori infection and food-cobalamin malabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Vitamin B12 levels during prolonged treatment with proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Effect of Hydrochloric Acid on Iron Absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Diagnosis of iron-deficiency anemia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Update of nutrient-deficiency anemia in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Prevalence of anaemia in older persons: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Infectious diarrhea: Cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Use of acid-suppressing drugs and the risk of bacterial gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Serum magnesium and proton-pump inhibitors use: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

A case series of proton pump inhibitor-induced hypomagnesemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Omeprazole and refractory hypomagnesaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Drug-induced acute interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Systematic review: Proton pump inhibitor-associated acute interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-014-0166-4

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

12 December 2020

Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans

1 reference

12 December 2020

Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors

1 reference

12 December 2020

Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.

1 reference

12 December 2020

Use of proton pump inhibitors and mortality among institutionalized older people

1 reference

12 December 2020

Hypomagnesaemia due to use of proton pump inhibitors--a review

1 reference

12 December 2020

Effect of L-lactic acid on calcium absorption in rats fed omeprazole

1 reference

12 December 2020

Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration

1 reference

12 December 2020

Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.

1 reference

12 December 2020

Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin

1 reference

12 December 2020

Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy

1 reference

12 December 2020

Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals

1 reference

12 December 2020

Risk factors for falls with use of acid-suppressive drugs

1 reference

12 December 2020

Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care

1 reference

12 December 2020

Serum T4, T3, and TSH levels in primary hypothyroidism during replacement therapy with thyroxine

1 reference

12 December 2020

The importance of gastric hydrochloric acid in the absorption of nonheme food iron

1 reference

12 December 2020

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture

1 reference

12 December 2020

Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study

1 reference

12 December 2020

Clostridium difficile infection

1 reference

12 December 2020

A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism

1 reference

12 December 2020

Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption

1 reference

12 December 2020

Long-term prescribing of proton pump inhibitors in general practice

1 reference

12 December 2020

Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension

1 reference

12 December 2020

Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals

1 reference

12 December 2020

Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria

1 reference

12 December 2020

Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource

1 reference

12 December 2020

Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro

1 reference

12 December 2020

Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)

1 reference

12 December 2020

Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Use of acid-suppressive medications in hospitalized patients

1 reference

12 December 2020

The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure

1 reference

12 December 2020

High prevalence of cobalamin deficiency in elderly outpatients

1 reference

12 December 2020

Renal magnesium wasting associated with therapeutic agents

1 reference

12 December 2020

Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis

1 reference

12 December 2020

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

1 reference

12 December 2020

Hypomagnesemia induced by several proton-pump inhibitors

1 reference

12 December 2020

Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland

1 reference

12 December 2020

Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging

1 reference

12 December 2020

Cobalamin (Vitamin B12) deficiency: is it a problem for our aging population and is the problem compounded by drugs that inhibit gastric acid secretion?

1 reference

12 December 2020

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

12 December 2020

Proton-pump inhibitors and hypomagnesemic hypoparathyroidism

1 reference

12 December 2020

Prevalence of cobalamin deficiency in the Framingham elderly population

1 reference

12 December 2020

Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers

1 reference

12 December 2020

Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors

1 reference

12 December 2020

Blinded randomised controlled study of the effect of a discharge communication template on proton pump inhibitor prescribing

1 reference

12 December 2020

Glad you brought it up: a patient-centred programme to reduce proton-pump inhibitor prescribing in general medical practice.

1 reference

12 December 2020

Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux

1 reference

12 December 2020

Role of gastric colonization in the development of pneumonia in critically ill trauma patients: results of a prospective randomized trial

1 reference

12 December 2020

Systematic review of the risk of enteric infection in patients taking acid suppression

1 reference

12 December 2020

Megaloblastic anaemia due to vitamin B12 deficiency caused by small intestinal bacterial overgrowth: possible role of vitamin B12 analogues

1 reference

12 December 2020

Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms

1 reference

12 December 2020

10.1007/S40266-014-0166-4

Identifiers

DOI

1 reference

release_aj5q5tveove7fa6owgk2yd6iiu

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aj5q5tveove7fa6owgk2yd6iiu

24 November 2022

mapped directly with Wikidata item

1 reference